Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Umeclidinium is an antagonist of muscarinic acetylcholine receptors (Kis = 0.05-0.16 nM for M1-M5 human recombinant receptors).1,2 It inhibits acetylcholine-induced activation of recombinant M3 receptors in CHO cell membranes (IC50 = <10 nM).1 Umeclidinium attenuates methacholine-induced calcium release in human airway smooth muscle cells (EC50 = 10 µM) and bronchoconstriction in mice when administered intranasally (ED50 = 0.02 µg).1,3 Formulations containing umeclidinium have been used in the treatment of chronic obstructive pulmonary disease (COPD).
WARNING This product is not for human or veterinary use.
1. Discovery of novel 1-
2. Pharmacological characterization of GSK573719 (umeclidinium): A novel, long-
3. Intracellular interactions of umeclidinium and vilanterol in human airway smooth muscle. Int. J. Chron. Obstruct. Pulmon. Dis. 12, 1903-1913 (2017).